chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 45min after receiving the vaccines above he noticed the gradual onset of a pruritic erythematous rash affecting primarily his trunk with spread to his extremities as well as his face (perioribital, perioral).  No mucosal involvement.  Followed up with his primary care provider who provided topical therapies and systemic (benadryl) for dermatologic manifestations.  Reports that within weeks he also began to develop dyspnea on exertion, asthma like symptoms, and resting tachycardia that have all resulted in permanent need for medical therapies to control his symptoms.  Reports he is receiving ongoing evaluations with an Allergist, Cardiologist and Pulmonologist.
pt recv vax 6OCT95&26FEB96 pt exp chicken pox;the reporter felt the chicken pox was related to therapy w/varicella vax;
Headache by next morning; Low grade fever (max 100.4F); Joint aches; Muscle aches; Strong deltoid pain at injection site; Body heaviness; Fatigue; Chills in the night; Inability to sleep the first night; slight wooziness in the first 1-2 hours after injection; Pain in old injuries a couple days after; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 03May2021 at 09:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 11Apr2021 at 09:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 03May2021, 1-2 hours after the injection, the patient experienced slight wooziness. On 03May2021 at 21:30, the patient experienced low grade fever (maximum 100.4F), joint/muscle aches, strong deltoid pain at injection site, body heaviness, fatigue, chills in the night and inability to sleep the first night. On 03May2021, the patient underwent body temperature and the result was low grade fever (maximum 100.4 Fahrenheit). On an unknown date in May2021, couple of days after, patient experienced pain in old injuries. On 04May2021, by next morning, the patient experienced headache. The patient also reported that symptoms are generally began 12-15 hours after injection and primary symptoms were lasted for 24 hours from time of onset. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events slight wooziness, low grade fever (maximum 100.4F), joint/muscle aches, strong deltoid pain at injection site, body heaviness, fatigue, chills in the night, inability to sleep the first night, pain in old injuries and headache was recovered on an unspecified date in May2021.  No follow-up attempts are needed. No further information is expected.
pt developed symptoms of: weakness (to the point of difficulty walking),  pounding headache with vision changes, shortness of breath with exersion, upper abdominal pain, nausea, vomiting, rash on her legs, back and arms, heart pounding
Patient broke out rashes/bumps on her 2 wrists upon receiving vaccines. Took BENADRYL and it helped w/ rash and itchiness.
No adverse effects were reported; patients received improperly stored vaccine; This spontaneous report has been received from a registered nurse referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided.  On 19-APR-2019, the patient was vaccinated with one dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(rHA (recombinant human albumin))(PROQUAD) lot # R026351, expiration date 15-MAR-2020 for prophylaxis (dose detail, anatomical location and route of administration). The sterile diluent was stored according to the prescribing information. No adverse effects were reported.  The vaccines were exposed to temperature excursion in the range (minus 14 degree Celsius (C) to minus 10 degree C) (average minus 13.7 degree C) for a time frame of 30 minutes with previous temperature excursion (minus 14 degree Celsius (C) to minus 10 degree C) (average minus 12.6 degree C). Data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1904USA011917:
Pt notes he had J&J covid vaccine on 4/8. He states that immediately, he had L arm pain and low grade temps for 2 days. He notes in the past few days he started having a rash around his ankles and left wrist area. He has also had some intermittent tingling in the first 3 fingers of his L hand. He states this is worse with use of his computer. No weakness. The rash on his legs are b/l. He hasn't had any allergen exposure that he knows of. He tried benadryl which did not cause any change. He notes that the triamcinolone that was prescribed seemed to wrosen the rash. He currently has no tingling in his arms.
white tiny bumps on both arms (thousands of bumps) and inflamed (painful) right armpit lymph node, over 28 hours since injection
About 33 hours after 2nd Pfizer Covid vaccine my armpit lymph node(left side  only which is same as vaccine side) started to become painful and a bit swollen. It?s been 3 days since 2nd dose and still have this pain.   *only other symptoms were a headache first and 2nd day that went away with OTC.(excedrin migriane)
FEVER BLISTER TO UPPER LIP Narrative: PATIENT STATED THAT HE DEVELOPED FEVER BLISTERS TO TOP LIP X 1 WEEKS, DENIES PAIN
pt devel a band of redness @ inj site, rxn began 7-9 days p/vax;pt was reported to have recovered;pt also reported as allergic to sulfa;
Began with dizziness, lightheaded, difficulty with balance, progressing to difficulty walking and standing in 24 hours. Over 72 hours, unable to stand unsupported or walk unaided, vision changes.
Soreness, erythema at the site of injection.  Injection site is warm to the touch.
She got COVID; She got COVID; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received bnt162b2 (COMIRNATY), administration date 28Jun2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "She got COVID". The reporter called on behalf of her mother to inquire regarding the second dose of the Pfizer Biontech COVID 19 vaccine. She stated her mother received the first dose of the Pfizer Biontech COVID 19 vaccine on 28Jun2021. She got COVID and was told by a Pharmacist not to come to get the second dose. Caller wanted to know if her mother should restart the vaccine series or to get the second dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After 5 minutes felt the symptoms of shock. Rising anxiety and heart rate. Light headed and cold sweat. I felt like I would faint. I laid flat on the ground and was better in about a minute and could stand up and sit in a chair again. 15 minutes later I was relatively normal.
Information has been received from a mother concerning her son with a penicillin allergy who in July 2004 was vaccinated with MMR II/Varicella vaccine. There was no concomitant medications. In July 2004 the patient had stomach cramps. The patient sought unspecified medical attention. As of 19 Sept 2006 the patient was recovering. It was also noted that the patient's brother experienced an adverse reaction after vaccination with MMR II/Varicella vaccine (WAES0609USA04260). Additional information is not expected.
Five hospitalizations since vaccination. Dx with auto-immune disorder-severe rheumatoid arthritis, flu-like symptoms, and clotting disorder. Onset within 4 weeks of 1st vaccine to present.
I had an abrupt, acute onset of constipation secondary to an engorged hemorrhoid, and painful abdominal cramps.   It was relieved after 2 enemas.  What is significant about this is that I HAVE NEVER EVER HAD CONSTIPATION IN MY LIFE, AND NEVER EVER HAVE HAD TO HAD (2) ENEMAS.  I am a physician, I eat a high fiber, low residue diet, exercise and drink plenty of water.
Per patient report "My vaccination was at 6:00 on 10/26. I ran a 101.5 fever while on ibuprofen and Tylenol on the night of, and day immediately after the vaccine and had terrible aches for a couple days. (Did not temp myself before I took the medicines) The hives showed up in the evening the following week at around 8pm or so. It was primarily on my left side, and the worst on my left hip. Aside from the ones on my hip they were only small nickel sized spots. I had a few single spots on my right arm.Under and above my bra line all the way around.The itching was mild, compared to poison ivy. I showered and took 2 benedryl around 8:30 By morning I was back to normal and I have not any symptoms since."
I have a metal plate installed on my right radius bone. During the 15 minutes after the shot injection, I felt stiffness around my plate. For approximately two weeks after the shot I continued to feel stiffness and pain in my right arm around my plate.
pt recv vax 19SEP94 & pt exp arm pain & tingling;reporter felt that there was a possible problem w/lot#
Patients arms are both swollen and inflammed a day after and she called again 2 weeks later to state they still were.
Information has been received from a physician concerning a 33 day old white male with no known drug allergies, and a history of maternal vaccine exposure, vaginal delivery, and an umbilical cord around neck, and a who had a family history of great grandfathers and grandfathers who had diabetes, cancer, epilepsy or seizures, asthma, high blood pressure, and stroke, who was vaccinated with a first, second, and third dose in the right thigh of hepatitis B virus vaccine on 04 Nov 2004 (Lot#649287/0410P), 27-Dec-2004 (Lot # 649286/0807P), and 05-Sep-2005 (Lot# 652221/0545R), respectively. Concomitant vaccines included a first, second, third, and fourth dose in the right thigh of Prevnar on 04-Nov-2004 (Lot # A67180B), 27-Dec-2004 (Lot# A57861K), 08-Mar-2005, and 05-Sep-2005 (Lot#A98339K), respectively, a first, second, and third dose in the left thigh of Tripedia on 04-Nov-2004 (Lot# X0P00), 27-Dec-2004 (Lot# X12121), and 08-Mar-2005, respectively. During a 6 month check up on 08-Mar-2005, the physician noted that the patient was breast feeding well and starting cereal. Initiation of solids was discussed. Normal void and stool was reported. Normal stooling variants were discussed. One or two night feeding was reported. Normal sleep variants were discussed. There were no concerns about hearing or vision. Working and reaching for toys, cooing and babbling, turning to voice, and rolling over were reported. The patient was awake and alert. The anterior fontanelle was open, soft, flat. Red reflex was present bilaterally. Tympanic membranes were normal bilaterally. Oropharynx was clear without erythema or exudates. Moist oral mucosa without lesions was reported. Heart had regular rate and rhythm without murmurs. Lungs were clear to auscultation bilaterally. Abdomen was soft, nontender, nondistended with normal bowel sounds and with no hepatosplenomegaly or palpable masses. Genitalia was normal. Femoral pulse was palpable. There were no hip clunks. There was full abduction bilaterally. There were symmetric skin folds on thighs. The patient moved all extremities well. There was good muscle tone and head control. Moderate pectus excavatum was noted. It was reported that the patient had cold symptoms, a low grade temperature according to the patient's mother, and a cough. The patient was treated with ibuprofen (Motrin), Augmentin ES, and Vigamox. The assessment was a well six month old with pectus excavatum. The plan was for routine health maintenance, anticipatory guidance, reassurance, expectant management, and to follow-up with nine month well child check up. The patient's vaccination history includes a first dose on the left thigh of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (Lot # 547107/0484R) on 06-Sep-2005, and a first dose in the left thigh of varicella virus vaccine live (Lot# 646666/0066R) on 06-Sep-2005. The patient previously experienced pectus excavatum following exposure to varicella virus vaccine live (WAES# 0401USA01755). Additional information has been requested.
Description: 11/10/98. Received anthrax vaccine #1- denies problems. 11/24/98. Received anthrax vaccine #2- denies problems. 12/11/98. Received anthrax vaccine #3- pt. states 4 wks after receiving the vaccine, noticed that he was "tripping over repeatedly over right foot"- occurred once a week- no change in sx intensity/frequency until April '99. April '99. "It would happen every time I walk"- bilat (R>L)- "but I got used to it"- attributed tripping to his military boots- pt. also started to experience "tingling" of his feet (occurred only after running, R>L) and constant burning and numbness (1/10, R>L)- radiating up to bilat knees- by August '99, foot drop had dissipated completely- no change noted in frequency/severity of above mentioned peripheral neuropathy sxs. 8/20/99. Received anthrax vaccine #4- states 2 wks after receiving the anthrax vaccination- noticed reoccurrence of foot drop- occurring QOD- and worsening of sxs of neuropathy (3/10). 3/13/00. Received anthrax vaccine #5- states 2 wks after receiving the anthrax vaccination- noticed constant paresthesis of feet (3/10)- no change in severity of foot drop and other peripheral neuropathy sxs. 7/6/05. Pt. seen by his Case Manager- states foot drop persists- occurs QD "most of the times when I am walking"- also c/o persistent paresthesis (3-4/10), numbness (4/10), burning sensation (5/10), of bilat feet (R>L)- notes sxs increase in intensity "only first minutes" after exercise (6-7/10). Since 2004, states noticed above peripheral neuropathy sxs radiating above bilat knees- denies any stiffness or imbalance- no c/o limited ROM- denies any h/o trauma or injury to his legs- no h/o lumbar injury/surgery/pain- states is taking NEURONTIN for his sxs- denies any alleviating factors- h/o congenital flat feet- pt. also states has began to notice mild bilat hand weakness.
This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 22-SEP-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # L007720 Expiration date: 08-JUL-2016, 0.5 ml (route and anatomical location of administration were not reported). The vaccine had three temperature excursions one of 328 hours with a lowest recorded temperature of 29 Fahrenheit (F) (-1.666666667 Celsius (C)), the other one of 264 hours with a lowest recorded temperature of 33 F (0.555555556 C) and the third one of 64 hours with a highest recorded temperature of 48 F (8.888888889 C). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor Product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
miscarriage of pregnancy, subsequent d & c at medical facility 12/11/09 MR records received. OB records for 9/15/09. DX: IUP 8wks by US. Advanced maternal age.
Fluvirin with Thimerosal given to OB pt.  LMP: 6/3/09.  EDC: 03/09/2010.  Pt does not have an ob/gyn.  Pt notified on 11/06/2009.  Denies any adverse effects.  Pt not hospitalized after receiving H1N1 vaccine. 11/24/2009 MD records, vaccine given to pregnant patient, no side effects reported at this time.
Patient felt like she was going to pass out. Vitals at 8:15, HR 81, SpO2 98%, BP 105/73. Vitals at 8:27, HR 68, SpO2 100, BP 105/73
Prolonged seizure at 5 AM the morning following administration of vaccines.   12/18/08 Received ER medical records of 11/12/2008. FINAL DX: status epilipticus Records reveal patient experienced general seizure x approx 10 min.  Tx w/meds & transferred to higher level of care.  1/20/09 Received hospital medical records of 11/12-11/13/2008. FINAL DX: complex febrile seizure Records reveal patient experienced generalized tonic-clonic seizures w/fever 101.5.  Tx w/meds & admitted to PICU.  Neuro consult obtained.  No further seizures overnight & d/c to home on no meds.
01/19/22 presents to Birth Center Triage for "contractions" "37w3d" "COVID, positive test 7 days ago". PMHx for "Hypothyroidism"
COVID breakthrough case. I received my 2nd booster shot on 04/10/2022, my adverse event started on 05/10/2022. In  the morning I had cough, sore throat, low grade fever most evening 99-100 and 2 nights it went to 102. I also body aches. I felt like my head was stuffed up. It was hard for me to go up the steps. I took a COVID home test yesterday on 05/17/2022 which was positive. Then I called my doc she prescribed Paxlovid for 5 days. Am still on the medications. I took 3 pills yesterday and few today. I guess it will take few more days to get better.
Received vaccine on Sun, 1/10, felt fine initially. On Tues, 2 days later, first noticed rash and hives to chest and back. He took Benadryl on Tues and Weds with some relief. He reported no SOB, no diff breathing, no throat itching, no chest tightness. He is a Cook on the tray line, very hot environment, may be related to the heat/sweating from the location where he works. He went to urgent care on 1/13, was given allergy medication and told to use Benzoyl Peroxide soap wash. He states the hives look better as of Thurs, 1/14. He was not seen by Occupational health, but did review case with employee via phone. He gave consent to have the reaction discussed with Allergy and he has completead a WSIRS with supervisor already.
Pt received Moderna COVID-19 vaccines on 2/15/2021 and 3/15/2021, subsequently admitted to hospital and diagnosed on with COVID with positive COVID test on 4/5/2021
States having difficulty breathing and wheezing within a day or so of vaccine and lasted 5 days (given 8/25/10). Student reported the above information on 9/28/2010.
low grade fever, chills, body aches (neck and back), fatigue, headache.
The Pharmacist that gave me the shot injected my arm way lower that it should of been. Normally the flu shot is given in the upper arm, 3 fingers below the shoulder. I did notice that the Pharmacist wiped my upper arm with alcohol, then proceeded to give me the shot in the lower part of my arm. The injection itself was way more painful than it normally is, maybe because the site of injection was completely wrong. The next day my arm was really sore and a little red but, I didn't think too much of it. That Monday (2 days later) my arm was extremely sore, and very hot to touch. I called the Pharmacy and they said they would like me to come in so, they can see. I went straight from work to the Pharmacy to show the Pharmacist Manager what the injection site looked like, she was very alarmed and thought the site could be "Mersa" and advised me to go to a Emergency Facility immediately to rule out.  The Dr at urgent care prescribed me Antibiotics and Pain Meds (Sulfameth & Naproxen) to start ASAP as he said I have a skin infection.
On day 3 post dose, I noticed that I had a large cutaneous eruption around the injection site (left deltoid).  It was erythematous with a well-defined raised border, not indurated.  It was warm to the touch and tender.  It was somewhat pruritic.  It was about 13 cm down my upper extremity and about 8cm around the circumference.    Now, at day 7, it is no longer tender at all, no longer pruritic, and only mildly erythematous.  I never did administer any treatment at all (I saw no need).
extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extremely tired) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jul-2021, the patient experienced FATIGUE (extremely tired). On 23-Jul-2021, FATIGUE (extremely tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.  Concomitant medication was not provided.  She saw 2 Dalmatians in her room, it always happened in the dark, and happened 4 times over about a week.   This case was linked to MOD-2021-318104 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-317611:Same reporter and Patient but different patient
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 19-JAN-2016 the patient was vaccinated with an improperly stored dose of ROTATEQ oral dose, 10-pack (lot # K010224, expiration date 13-MAY-2016). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 536 hours with the lowest recorded temperature of 1.11 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a healthcare professional (medical assistant) and refers to a 4 year old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions and concomitant therapies was provided. On 02-FEB-2016, the patient was vaccinated with a dose of ZOSTAVAX (lot # L034724, expiration date 09-DEC-2016, exact dose and route of administration were not reported) in error. The patient was indicated to receive VARIVAX (Merck) (lot # and expiration date were not reported). The reporter did not know why the error occurred, but she stated that the ZOSTAVAX vials were in the freezer beside the VARIVAX (Merck). The patient had not reported an adverse experience. Additional information has been requested.